1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Whistleblower News

Forum for posting and discussion of whistleblower news


Sort By:
Title
Replies Views
Last Message ↓
  1. cafead
    Replies:
    0
    Views:
    96
  2. cafead
    Replies:
    0
    Views:
    82
  3. cafead
    Replies:
    0
    Views:
    135
  4. cafead
    Replies:
    0
    Views:
    86
  5. cafead
    Replies:
    0
    Views:
    91
  6. cafead
    Replies:
    0
    Views:
    117
  7. cafead
    Replies:
    0
    Views:
    124
  8. cafead
    Replies:
    0
    Views:
    99
  9. cafead
    Replies:
    0
    Views:
    129
  10. cafead
    Replies:
    0
    Views:
    403
  11. cafead
    Replies:
    0
    Views:
    132
  12. cafead
    Replies:
    0
    Views:
    106
  13. cafead
    Replies:
    0
    Views:
    55
  14. cafead
    Replies:
    0
    Views:
    196

Thread Display Options

Loading...